Evidence map›Paper›PMID 27474101›Full record

ArticleBiostatistics (Oxford, England)2017

A unified powerful set-based test for sequencing data analysis of GxE interactions.

Yu-Ru Su, Chong-Zhi Di, Li Hsu, Genetics and Epidemiology of Colorectal Cancer Consortium

Open access · bronzeAbstract read
In one paragraph

Article in Biostatistics (Oxford, England), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Gene-environment interactions in human health.Nature reviews. Genetics · 2024
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Exploratory Genome-Wide Interaction Analysis of Nonsteroidal Anti-inflammatory Drugs and Predicted Gene Expression on Colorectal Cancer Risk.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Yu-Ru SuBiostatistics and Biomathematics Program, Public Health Science Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N, Seattle, WA 98109, USA lih@fredhutch.org.
Chong-Zhi DiBiostatistics and Biomathematics Program, Public Health Science Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N, Seattle, WA 98109, USA lih@fredhutch.org.
Li HsuBiostatistics and Biomathematics Program, Public Health Science Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N, Seattle, WA 98109, USA lih@fredhutch.org.
Genetics and Epidemiology of Colorectal Cancer Consortium
Fred Hutch Cancer Center · US

Funding

Molecular pathological epidemiology of colorectal cancerU01CA137088 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI PETERS, ULRIKE · 2009 to 2018
$21.8M
Detection of Colorectal Cancer Susceptibility Loci Using Genome-Wide SequencingU01CA164930 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI PETERS, ULRIKE · 2012 to 2015
$12.4M
Use of Biomarkers in Diagnosis, Prognosis, Risk Prediction and Early Detection ofP01CA053996 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI HSU, LI · 1991 to 2015
$9.4M
Statistical Methods for Analysis of Tumor Heterogeneity in Genetic EpidemiologyR01CA189532 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI HSU, LI · 2015 to 2023
$4.2M
Statistical Methods for Genetic Epidemiology StudiesR01CA195789 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI HSU, LI · 2016 to 2019
$1.6M
FHCRC High-Performance Computing ClusterS10OD020069 · OD · FRED HUTCHINSON CANCER RESEARCH CENTER · PI KOOPERBERG, CHARLES L · 2015 to 2015
$600k
Statistical methods for GxE interactions: Measurement error & time varying exposuR21ES022332 · NIEHS · FRED HUTCHINSON CANCER RESEARCH CENTER · PI DI, CHONGZHI · 2013 to 2014
$481k
Using Functional Data to Reveal Gene-Environment Interaction in Colorectal CancerR21CA191312 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI HSU, LI · 2015 to 2016
$421k
NCI NIH HHS P01 CA053996NCI NIH HHS R01 CA189532NCI NIH HHS R01 CA195789NCI NIH HHS R21 CA191312NCI NIH HHS U01 CA137088NCI NIH HHS U01 CA164930NIEHS NIH HHS R21 ES022332NIH HHS S10 OD020069
6 · The paper itself

Abstract

The development of next-generation sequencing technologies has allowed researchers to study comprehensively the contribution of genetic variation particularly rare variants to complex diseases. To date many sequencing analyses of rare variants have focused on marginal genetic effects and have not explored the potential role environmental factors play in modifying genetic risk. Analysis of gene-environment interaction (GxE) for rare variants poses considerable challenges because of variant rarity and paucity of subjects who carry the variants while being exposed. To tackle this challenge, we propose a hierarchical model to jointly assess the GxE effects of a set of rare variants for example, in a gene or regulatory region, leveraging the information across the variants. Under this model, GxE is modeled by two components. The first component incorporates variant functional information as weights to calculate the weighted burden of variant alleles across variants, and then assess their GxE interaction with the environmental factor. Since this information is a priori known, this component is fixed effects in the model. The second component involves residual GxE effects that have not been accounted for by the fixed effects. In this component, the residual GxE effects are postulated to follow an unspecified distribution with mean 0 and variance [Formula: see text] We develop a novel testing procedure by deriving two independent score statistics for the fixed effects and the variance component separately. We propose two data-adaptive combination approaches for combining these two score statistics and establish the asymptotic distributions. An extensive simulation study shows that the proposed approaches maintain the correct type I error and the power is comparable to or better than existing methods under a wide range of scenarios. Finally we illustrate the proposed methods by a exome-wide GxE analysis with NSAIDs use in colorectal cancer.

Indexed as

Gene-Environment InteractionModels, GeneticModels, StatisticalHumansSequence Analysis, DNABurden and variance component testsColorectal cancerKernel machineRare genetic variantsScore test

Identifiers

PMID27474101
PMCPMC5255050
OpenAlexW2495007030

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.